Baseline clinical and demographic data
| n (%) | Median | Range | Mean | SD | |
|---|---|---|---|---|---|
| Age | 127 (100) | 68 | 63 (26–89) | 66.2 | 12.6 |
| Gender (male) | 47 (80) | ||||
| Australian-modified Karnofsky Performance Status Score | 126 (99) | 60 | 70 (20–90) | 56.7 | 15.7 |
| Body mass index | 101 (80) | 23.7 | 20 (13.9–33.9) | 24.1 | 4.1 |
| C reactive protein | 32 (25) | 76.5 | 378 (5–383) | 102.2 | 85.9 |
| Calculated creatinine clearance | 71 (56) | 70 | 239.1 (0.9–240) | 74.5 | 36.4 |
| National Cancer Institute Common Toxicity Grading for Pain | 127 (100) | 2 | 2 (1–3) | 2.33 | 0.64 |
| Primary life-limiting illness | |||||
| Cancer | 121 (95.3) | ||||
| End-stage renal disease | 2 (1.6) | ||||
| End-stage respiratory disease | 1 (0.8) | ||||
| Other (severe peripheral vascular disease (1), unrecorded (2)) | 3 (2.4) | ||||